Home Intravenous Versus Oral Antibiotics Following Appendectomy for Perforated Appendicitis in Children: a Randomized Controlled Trial
Overview
Pediatrics
Authors
Affiliations
Purpose: To compare the effect of home intravenous (IV) versus oral antibiotic therapy on complication rates and resource utilization following appendectomy for perforated appendicitis.
Methods: This was a randomized controlled trial of patients aged 4-17 with surgically treated perforated appendicitis from January 2011 to November 2013. Perforation was defined intraoperatively and divided into three grades: I-contained perforation, II-localized contamination to right gutter/pelvis, and III-diffuse contamination. Patients were randomized to complete a ten-day course of home antibiotic therapy with either IV ertapenem or oral amoxicillin-clavulanate. Thirty-day postoperative complication rates including abscess, readmission, wound infection, and charges were compared.
Results: Eighty-two patients were enrolled. Forty four (54%) were randomized to the IV group and 38 (46%) to the oral group. IV patients were older (12.3 ± 3.6 versus 10.1 ± 3.6, p < 0.05) with higher BMI (20.9 ± 5.8 versus 17.9 ± 3.5, p < 0.05). There were no differences in gender, comorbidities, or perforation grade (I-20.4% vs. 26.3%, II-36.4% vs. 34.2%, III-43.2% vs. 39.5%, all p > 0.05). Comparing IV to oral, there was no difference in length of stay (4.4 ± 1.5 versus 4.4 ± 2.0 days, p > 0.05), postoperative abscess rate (11.6% vs. 8.1%, p > 0.05), or readmission rate (14.0% vs. 16.2%, p > 0.05). Hospital and outpatient charges were higher in the IV group (p < 0.0001).
Conclusion: Oral antibiotics had equivalent outcomes and incurred fewer charges than IV antibiotics following appendectomy for perforated appendicitis.
Perforated Appendicitis in Children: Management, Microbiology, and Antibiotic Stewardship.
Snyder K, Hunter C, Buonpane C Paediatr Drugs. 2024; 26(3):277-286.
PMID: 38653916 DOI: 10.1007/s40272-024-00630-0.
Pediatric perforated appendicitis diagnosis based on the C-reactive protein/prealbumin ratio.
Long J, Zhang J, Chen G, Su X, Qiu B, Dong Q Sci Rep. 2024; 14(1):6729.
PMID: 38509094 PMC: 10954718. DOI: 10.1038/s41598-024-55108-3.
Zhao R, Long X, Wang J, Zhu J, Liu C, Shang T Front Pediatr. 2022; 10:982179.
PMID: 36324821 PMC: 9620802. DOI: 10.3389/fped.2022.982179.
Opinion-Based Recommendations: Beware the Tyranny of Experts.
Spellberg B, Shorr A Open Forum Infect Dis. 2021; 8(11):ofab490.
PMID: 34805432 PMC: 8599712. DOI: 10.1093/ofid/ofab490.
Plattner A, Newland J, Wallendorf M, Shakhsheer B Infect Dis Ther. 2021; 10(4):2247-2257.
PMID: 34287780 PMC: 8572942. DOI: 10.1007/s40121-021-00502-x.